NCT06776419View on ClinicalTrials.gov

the Role of cArdiac Inflammation, endoThelial Dysfunction, and FIbrosis in fabrY Disease

RecruitingOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

December 1, 2030

Study Completion Date

June 1, 2031

Conditions
Fabry DiseaseCardiovascular Diseases
Interventions
DIAGNOSTIC_TEST

Cardiac Magnetic Ressonance Imaging

CMR-protocol with gadolinium contrast

DIAGNOSTIC_TEST

82Rubidium-positron emission tomography and computer-tomography

cardiac Rb-PET protocol

Trial Locations (1)

2100

RECRUITING

Rigshospitalet, Copenhagen

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Caroline Michaela Kistorp

OTHER